Center of Respiratory Medicine, China-Japan Friendship Hospital; National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College; State Key Laboratory of Respiratory Health and Multimorbidity; Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education;Public Health Emergency Management Innovation Center, Beijing, People's Republic of China.
BMJ Open. 2024 Aug 29;14(8):e081295. doi: 10.1136/bmjopen-2023-081295.
We aimed to investigate the risk factors for acute kidney injury (AKI) after normotensive pulmonary embolism (PE) and the impact of anticoagulation on renal recovery.
Multicentred, retrospective cohort study.
Data from four tertiary hospitals in China were captured. All available measurements of serum creatinine (SCr) during hospitalisation and follow-up were collected.
Patients with acute PE and those without haemodynamic instability were enrolled. All recruited patients were followed up for up to 2 years.
The primary outcome was the occurrence of AKI, defined by the Kidney Disease Improving Global Outcomes criteria. The secondary outcome was the recovery of renal function. The time interval between PE onset and the initiation of anticoagulation was analysed to obtain its influence on the recovery of renal function.
A total of 461 patients with acute normotensive PE were enrolled. A transient elevation of SCr during hospitalisation was observed. The incidence of AKI among normotensive patients was 18.9%. Brain natriuretic peptide (BNP) NT-proBNP elevation (adjusted HR (aHR) 2.27, 95% CI 1.33 to 3.86) and history of chronic kidney disease (aHR 4.81, 95% CI 2.44 to 9.48) were associated with the development of AKI during hospitalisation. Earlier initiation of anticoagulation therapy (within 5 days after PE onset, compared with over 6 days) promoted an early recovery of renal function (adjusted OR 0.26, 95% CI 0.08 to 0.84, p=0.025).
Renal impairment and AKI were highly prevalent among patients with normotensive patients. The occurrence of AKI was associated with right heart function. Patients who developed AKI after PE would benefit from earlier anticoagulation therapy for an early recovery of renal function.
本研究旨在探讨血压正常的肺栓塞(PE)后急性肾损伤(AKI)的危险因素,以及抗凝治疗对肾功能恢复的影响。
多中心、回顾性队列研究。
数据来自中国的 4 家三级医院。收集了住院期间和随访期间所有血清肌酐(SCr)的检测值。
纳入急性 PE 患者和无血流动力学不稳定的患者。所有入组患者均随访 2 年。
主要结局是采用肾脏病改善全球结局(KDIGO)标准定义的 AKI 发生情况。次要结局是肾功能恢复情况。分析 PE 发病至开始抗凝治疗的时间间隔,以了解其对肾功能恢复的影响。
共纳入 461 例血压正常的急性 PE 患者。住院期间观察到 SCr 一过性升高。血压正常患者 AKI 的发生率为 18.9%。脑钠肽(BNP)NT-proBNP 升高(校正 HR(aHR)2.27,95%CI 1.33 至 3.86)和慢性肾脏病史(aHR 4.81,95%CI 2.44 至 9.48)与住院期间 AKI 的发生相关。早期抗凝治疗(PE 发病后 5 天内,与超过 6 天相比)促进了肾功能的早期恢复(校正 OR 0.26,95%CI 0.08 至 0.84,p=0.025)。
血压正常的 PE 患者中肾功能损害和 AKI 发生率较高。AKI 的发生与右心功能相关。PE 后发生 AKI 的患者,早期抗凝治疗有利于肾功能的早期恢复。